Glow peptide therapy in Las Vegas

Glow is a compounded peptide blend: one prescription, one vial, three peptides. The three are GHK-Cu, a copper binding tripeptide that occurs naturally in human plasma, plus BPC-157 and TB-500. A licensed pharmacy prepares the vial for one patient. We dispense it as a one month supply for $225, a nurse or REMT teaches the first dose in your home or hotel, and the vial stays with you.

A one month supply of Glow is $225. That is a supply price for the take-home vial, not a per visit fee. It covers the provider review, the patient specific vial, the visit where a licensed nurse or REMT teaches you to draw up and give the first dose, and the kit that stays with you. Your provider confirms the final cost at your consultation, and refills are quoted only after a provider reviews how the supply went.

No. GHK-Cu, BPC-157 and TB-500 are compounded substances, not FDA approved medicines, so the blend is not an FDA approved product. It is prepared by a licensed pharmacy on an individual prescription and is not evaluated by the FDA before dispensing. In July 2026 an FDA advisory committee reviewed BPC-157 and TB-500 for possible inclusion on the list of substances pharmacies may compound. That review is a step in a process, not an approval, and it does not change the answer above.

Composition and price. Glow is GHK-Cu, BPC-157 and TB-500, dispensed as a one month supply at $225. Klow is those same three peptides with KPV added, dispensed as a one month supply at $240. Both are compounded on an individual prescription and taught in person at the first dose. Which one is appropriate for you, or whether either is, is a clinical judgment your provider makes with your history in front of them, so this page will not tell you one is better than the other.

Your provider sets it, and we will not publish a number. Dosing depends on your history and on what the prescription says. Your nurse writes the schedule down and leaves it with your kit, and the supply is dispensed as one month. Any change to that schedule comes from your provider, not from us and not from a dosing chart you found online.

Subcutaneously, using the technique your nurse demonstrates at the first visit. You draw up and give that first dose yourself with the nurse guiding you, you practice until you are comfortable, and you rotate sites and log them as they show you. We do not publish an injection map or a needle size, because the right answer depends on your prescription and on what you were taught in person.

The honest starting point is what is not known. A 2025 systematic review of BPC-157 included 36 studies, 35 of them preclinical, and reported that no clinical safety data were found. Human data across all three peptides is limited. Injection site reactions are the ordinary thing to expect from any subcutaneous injection. Anything beyond that is a question for your provider, who reviews your history and tells you what to watch for and when to call.

One month. The supply is dispensed as a one month supply, and it runs out at the end of that period. A refill is not automatic: your provider reviews how the supply went and decides whether continuing is appropriate before anything else is dispensed.

This is the question that shows what the evidence looks like. Nothing published establishes what the blend does while you are taking it, so nothing published establishes what changes when you stop. We are not going to invent an answer. If you are deciding whether to continue or stop, that is a conversation with the provider who prescribed it, and it should happen before the supply runs out rather than after.

We can tell you exactly what the $225 buys, and you can judge the rest. It buys a provider review of your history, a vial compounded for you alone, a visit where a licensed nurse or REMT teaches you to inject, the kit and sharps container that stay with you, and a phone number to call when you have a technique question. It does not buy a promised result, because none of the three peptides has published evidence that would support promising one.

Yes. A licensed provider reviews your health history, medications and goals in a good-faith exam before anything is prescribed. That consultation does not guarantee a prescription. If Glow is not clinically appropriate for you, we say so and talk through what else is on the menu.

Yes, after the first one. A licensed nurse or REMT comes to you, and you draw up and give that first dose yourself with them guiding you through every step. You practice until you are comfortable. The vial and the supplies stay with you, and you continue on the schedule your provider set. The nurse is reachable by phone if a technique question comes up later.

That is a clinical decision, so your provider makes it rather than a web page. Tell them if you are pregnant, trying to conceive or breastfeeding, and bring your full medication list and any active diagnoses. One thing worth flagging up front: USADA lists BPC-157 as prohibited at all times and thymosin beta-4 derivatives including TB-500 are prohibited too, so if you compete under an anti doping code, check its rules before you book.

We strongly advise against it. Products sold online as research chemicals are not dispensed for human use, come with no prescriber, and carry no verified identity, purity or sterility. USADA states there is no legal basis to include BPC-157 in any compounded medication outside the prescription route, and nobody selling a vial off a website is reviewing whether it is appropriate for you or answering the phone if something goes wrong.

Generally no. Peptide therapy is considered elective and is paid out of pocket. We publish the supply price so you can see what it costs before you book anything.

Across the Las Vegas Valley, including Henderson, North Las Vegas, Paradise, Enterprise, Summerlin South, Sunrise Manor, Winchester and Whitney. A licensed nurse or REMT comes to your home, office, or hotel. Call 725-217-4236 to confirm coverage for your address.